Status:

RECRUITING

Robotic Apparel to Prevent Freezing of Gait in Parkinson Disease

Lead Sponsor:

Harvard Medical School (HMS and HSDM)

Collaborating Sponsors:

Michael J Fox Foundation for Parkinson Research

Boston University

Conditions:

Parkinson Disease (PD)

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Freezing-of-gait (FoG) in Parkinson Disease (PD) is one of the most vivid and disturbing gait phenomena in neurology. Often described by patients as a feeling of "feet getting glued to the floor," FoG...

Detailed Description

Wearable robots are capable of augmenting spatiotemporal gait mechanics and are emerging as viable solutions for locomotor assistance in various neurological populations. Given the breakdown of spatio...

Eligibility Criteria

Inclusion

  • 18-90 years old
  • Self-reported Freezing of Gait due to PD
  • Score of 21 or higher on the cognitive screening test (Montreal Cognitive Assessment Score (MoCA))
  • Independent ambulation (with or without an assistive device, no physical assistance) for at least 20 meters
  • Able to understand, communicate, and be understood by study staff
  • Provide HIPAA Authorization to allow communication with the participant's treating physician/provider for medical clearance (if deemed necessary by study clinical team) to verify self-reported medical history (if deemed necessary by study clinical team)
  • Provide informed consent
  • Ability to participate in 8 research study visits

Exclusion

  • More than 2 falls in the previous month, as a result of gait impairment (may enroll under clinician discretion)
  • Major surgery in the last 6 months that interferes with walking (may enroll under clinician discretion)
  • Gait deficits due to missing limbs
  • Experience chronic pain that interferes with walking ability (may enroll under clinician discretion)
  • Serious co-morbidities (unrelated to gait impairment) that may interfere with ability to participate in research (e.g. cardiovascular, neurological, skin, and vascular conditions such as acute, ongoing/unmanaged deep vein thrombosis)
  • No observable freezing-of-gait

Key Trial Info

Start Date :

September 3 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2027

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06602544

Start Date

September 3 2024

End Date

September 1 2027

Last Update

July 18 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Harvard Science and Engineering Complex

Allston, Massachusetts, United States, 02134

2

Boston University Sargent College of Health and Rehabilitation Sciences

Boston, Massachusetts, United States, 02215